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Abstract
Treatment planning is an essential step of the radiotherapy workflow. It has become more sophisticated over the past couple of
decades with the help of computer science, enabling planners to design highly complex radiotherapy plans to minimize the normal
tissue damage while persevering sufficient tumor control. As a result, treatment planning has become more labor intensive,
requiring hours or even days of planner effort to optimize an individual patient case in a trial-and-error fashion. More recently,
artificial intelligence has been utilized to automate and improve various aspects of medical science. For radiotherapy treatment
planning, many algorithms have been developed to better support planners. These algorithms focus on automating the planning
process and/or optimizing dosimetric trade-offs, and they have already made great impact on improving treatment planning
efficiency and plan quality consistency. In this review, the smart planning tools in current clinical use are summarized in 3 main
categories: automated rule implementation and reasoning, modeling of prior knowledge in clinical practice, and multicriteria
optimization. Novel artificial intelligence–based treatment planning applications, such as deep learning–based algorithms and
emerging research directions, are also reviewed. Finally, the challenges of artificial intelligence–based treatment planning are
discussed for future works.
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Introduction
Artificial intelligence (AI) has recently become one of the most
popular words in both industry and academia. Properly known
as a modern technology term, AI was perceived as a powerful
entity that could “think and act humanly without losing
rationality.”1 In computer science fields, AI is defined as the
study of algorithms and devices that perceive information from
the environment and take action to maximize the chance of
achieving specific goals.2 Due to the rapid increases in compu-
tational power as well as in data collection and sharing cap-
abilities, a large number of AI techniques, particularly deep
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learning theories and algorithms, have been published in recent
several years. Following this burst of techniques, AI has per-
meated nearly every aspect of our lives and is rapidly revolu-
tionizing how we live. In the field of radiation oncology, the AI
revolution has also been grounded in the automated support of
various parts of the radiotherapy clinical workflow: target and
tissue segmentation, treatment planning, radiotherapy delivery,
and treatment response assessment. This article reviews auto-
matic treatment planning (ATP) tools in radiotherapy treatment
planning, which have evolved from simple automation execu-
tion to the development of AI as a future replacement of current
day manual treatment planning process. Artificial intelligence
in radiotherapy treatment planning, particularly deep learning–
based investigations, would be the focus of this article. Artifi-
cial intelligence applications in other aspects of radiotherapy
such as autosegmentation, image processing, or QA can be
found in other reviews.3,4
Radiotherapy treatment planning, especially inverse treat-
ment planning, is a laborious process taking hours or even days
to complete. Figure 1A shows a brief workflow of manual
treatment planning process in the current clinic practice. A
workflow starts with a list of dosimetric requirements, includ-
ing target coverage and organ-at-risk (OAR) constraints. Based
on the specific requirements of each case, a human planner
makes decisions about basic planning parameters, including
beam energy, number, angles, and so on. While generating a
minimally acceptable plan may be quick, improving a plan is
much less straightforward and often requires many iterations
between planners treatment planning system (TPS). In addi-
tion, physicians may need to interact with human planners back
and forth for plan improvement based on intermediate plan
results. The iterative nature of these interactions leads to tre-
mendous human efforts and time commitment.
Because of the automatic nature, ATP has successfully
reduced plan generation time, especially human interactions
(mostly repetitive operations) with TPSs.5,6 Thus, human plan-
ners are able to devote more time to explore the optimal dosi-
metry for individually optimized treatment planning.
Furthermore, the improved efficiency could also enable clinical
paradigm changes, including novel treatment planning strate-
gies,7 treatment course monitoring methods,8 and treatment
delivery workflows.9,10
Besides efficiency, ATP has also improved plan quality
consistency and error rate. Because conventional treatment
planning is a trial-and-error process exploring dosimetric and
clinical trade-offs, the final plan quality is dependent on both
planner experience and time available for planning. Many ATP
studies across various disease sites have reported a more con-
sistent treatment plan quality compared to manual plans.11-16
As such, ATP can reduce health-care disparities by making
advanced treatment planning expertise broadly available.17
Unlike efficiency and consistency, plan quality has not been
improved by current ATP techniques. While studies have
reported that machine-generated plans are clinically accepta-
ble, others have indicated that ATP requires essential human
tuning or manipulation to ensure acceptable quality and
safety.18,19 While humans should remain the center of treat-
ment planning for plan safety and quality, an important goal of
AI-based treatment planning algorithms is to augment treat-
ment plan quality. Many new approaches are currently being
explored in this area. In the following sections, we will review
the past efforts of ATP applications in current research direc-
tions, as well as future research topics and challenges.
Current ATP Techniques
This section summarizes the current ATP techniques in the past
decade. The literature was searched using National Library of
Medicine PubMed search engine, and key works regarding
technical developments and clinical investigations were
selected based on our clinic practice experience and our pro-
fessional society consensus. Based on the impact of clinic prac-
tice workflow, the current ATP solutions are organized into 3
categories for discussion20:
a. automated rule implementation and reasoning (ARIR);
b. modeling of prior knowledge in clinical practice; and
c. multicriteria optimization (MCO).
Automated Rule Implementation and Reasoning
In Figure 1A, human planners need to decide basic treatment
planning parameters. These decisions are usually determined
based on institutional guidelines as well as the planner’s indi-
vidual preferences, that is, rules with straightforward criteria.
For example, in upper esophagus planning, static beams are
often arranged in 2 “bouquets” avoiding lateral lung to reduce
lung V5 Gy. To explore the dose trade-offs, for example, OAR
dose constraints and target coverage, experienced human plan-
ners usually need a few trials with adjustments of planning
strategies by experienced planners.21 These adjustments are
typically simple combinations of basic operations in the TPS,
but the reasoning process may require complex, extensive
human knowledge, modeled by “if-then” binary actions.
To implement simple clinical guidelines with possible itera-
tive adjustments following binary logic, an automated com-
puter program with hard-coded rules and “if-then” structures
would be an ideal solution. Figure 1B shows a brief illustration
workflow of ARIR. As presented, the TPS directly analyzes
patient anatomy and dosimetric requirements and mimics the
reasoning process in manual treatment planning. Following a
well-defined logic reasoning scheme from human definitions,
ARIR can reduce the requirement of human operations in plan
generation (as presented in red arrow), particularly repetitive
operations.
Vendors of modern TPS have provided ARIR solutions to
enable scripting functions by users’ inputs. For example, Var-
ian Eclipse system (Varian Medical System, Palo Alto, Cali-
fornia) has a scripting application programming interface
function. This function, ESAPI, allows the user to build spe-
cific automatic programs for research and clinic use. Built in a
C# environment, ESAPI has function libraries that can simulate
2 Technology in Cancer Research & Treatment
most actions in the treatment planning process, including con-
tour manipulation, beam setup, inverse dose–volume histogram
(DVH) optimization, dose calculation, and plan statistics cal-
culation. Users dynamically adjust DVH constraints to
iteratively achieve a specific dosimetric goal after evaluation
of ongoing optimization results (ie, reasoning).22
Another available solution in enhanced integration is
AutoPlanning in the Pinnacle TPS (Philips Radiation Oncology
Figure 1. A, A brief workflow of manual treatment planning. B, A brief workflow of ARIR in treatment planning. C, A brief workflow of KBP
in treatment planning. D, A brief workflow of MCO in treatment planning. E, A brief workflow of AI use in future treatment planning. AI
indicates artificial intelligence; ARIR, automated rule implementation and reasoning; KBP, knowledge-based planning; MCO, multicriteria
optimization.
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Systems, Fitchburg, Wisconsin). Unlike ESAPI, AutoPlanning
is a fully developed product as an optional function in the
Pinnacle TPS. It does not involve computer program scripting;
instead, a planning template is required to list specific require-
ments in target prescription and OAR sparing.19 According to
the input template, AutoPlanning automatically generates aux-
iliary planning structures for spatial dose distribution manipu-
lation. Then the program starts the optimization and follows the
iterative process as in manual planning to fine-tune the plan
based on the input template. Some underlying settings, such as
cold/hot spot control, can be adjusted through the Pinnacle
platform (Philips Radiation Oncology Systems, Fitchburg,
Wisconsin).
Much work has been focused on realizing ATP through the
rule-based implementation of reasoning with vendor-specific
automation capabilities. While early efforts started in prostate
intensity-modulated radiotherapy (IMRT) planning,23
researchers have since focused on IMRT and volumetric modu-
lated arc therapy (VMAT) planning of head and neck cancer
due to its complex trade-off relationships in manual plan-
ning.6,12,24-26 Automation of rule-based implementation rea-
soning is frequently used with other machine learning
algorithms, with recent examples including rapid breast and
pelvis treatment planning.27,28
Modeling of Prior Knowledge in Clinical Practice
In human practice, a natural way to improve manual treatment
planning efficiency and quality is to review similar prior
“good” cases. Specifically, planning parameters in previous
cases, such as beam arrangements and DVH objectives in
inverse planning, can be introduced directly to the planning
process or used as decision references for a current case. Fol-
lowing this idea, researchers have developed statistical models
to extract certain features from prior “good” cases using best
clinical judgment and knowledge. When using corresponding
features from a current case as inputs, these models can predict
planning parameters with possible distribution intervals, which
can be used for treatment planning with improved efficiency.
This approach, also known as knowledge-based planning
(KBP), has gained popularity. Figure 1C projects a workflow
of KBP utilization. Information extracted from KBP can assist
human planners during initial decision-making. Such informa-
tion can be used as TPS input for certain automated processes.
In general, the use of KBP can potentially reduce the iterative
plan adjustments before reaching a satisfied treatment plan.
In DVH-based inverse optimization, DVH constraints are
important to high-quality plans; optimal constraints can
quickly lead to convergence with the balanced dosimetric out-
come. Thus, many studies have been developed for DVH-based
knowledge modeling. Specifically, a number of previous
acceptable or superior clinical cases of a given anatomical site
are used. The required case number (typically a few 10s) varies
widely in different clinical applications, which depend on treat-
ment sites, delivery techniques, and clinical evaluation stan-
dards.16 Characteristic relationships between these cases’ DVH
results and anatomical/geometrical features of target(s)/OARs
are established during the modeling process. For a new patient
with the same anatomical site, a set of achievable DVH curves,
including both target(s) and OARs, can be predicted by the
model. The predicted DVH curves can be used as references
for the human to select DVH constraints during the manual
planning process or as the inputs for an automated treatment
planning workflow.
A representative DVH-based knowledge modeling method
was published by Yuan et al.29 In their work, models for pros-
tate and head and neck IMRT treatments were built. The geo-
metry of an OAR relative to the planning target volume (PTV)
was represented by the distance-to-target histogram (DTH),
and characteristic geometry and dosimetric features were
derived from DTH and DVH by principal component analysis
(PCA), respectively. Results showed good OAR dose predic-
tion results in both modeled sites. This DVH-based knowledge
modeling has been commercially developed as RapidPlan by
Varian (Varian Medical System) as an optional function in the
Eclipse TPS. Besides RapidPlan, a number of research studies in
DVH-based knowledge modeling methods have been reported
for a variety of treatment sites, including prostate,30-33 brain,34
head-and-neck,35-37 lung,38-40 liver,41 and pelvis.42
The key limitation of DVH-based approach is the lack of
spatial information, and the planners may need extra work to
deal with a case with uncommon OAR/target geometry. Thus,
in addition to the DVH-based approach, knowledge-based
modeling has been reported for voxel-based prediction, in
which dose values of individual voxels are predicted with pre-
served spatial information.43-45 Knowledge-based modeling
has also been reported for beam angle arrangement for lung
IMRT treatment.46,47
Multicriteria Optimization
In the DVH-based inverse optimization of most commercially
available TPS, a cost function has to be defined for the mini-
mization problem. This cost function combines information
from all volumes of interest as a weighted sum of the penalty
from each dosimetric criterion from DVH constraints. The
trade-off between the target(s) and different OARs is repre-
sented by the weighting coefficient of each criterion. The draw-
back of this approach is the requirement of reoptimization if the
dosimetric preference of humans is changed during plan eva-
luation. Thus, finding the optimal trade-off may become time-
consuming. To overcome this issue, MCO was proposed to
generate multiple “anchor” plans simultaneously instead of a
single plan during the inverse planning process. In each anchor
plan, a single DVH criterion of OAR is optimized for best
sparing without compromising tumor target dosimetric cri-
teria.48,49 These plans will form a hypersurface in the
N-dimension space, where N is the number of independent
(ie, competing) OAR dosimetric criteria. Referred to as the
Pareto surface, this hypersurface contains the optimal plans
following different dosimetric criteria. Figure 1D shows a
workflow using MCO in treatment planning. Clinicians can
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interactively work with TPS: Specifically, one can navigate
through a series of Pareto-optimal plans on different Pareto
surfaces with linear interpolations to choose an optimal plan
based on the clinicians’ evaluation of all dosimetric criteria.50
Thus, if one changes the dosimetric criteria in plan evaluation,
the optimal plan can be found in a very short time without
reoptimizations from human planners.
In theory, MCO requires the generation of many plans to
form the Pareto surface, which may become very time-
consuming even with automation. Craft and Bortfeld analyzed
head and neck IMRT plans and proved that only a small num-
ber of plans are needed to form the Pareto database of feasible
plans through objective correlation matrices and PCA of the
beamlet solutions.51 Specifically, if N-independent dosimetric
criteria are defined, N þ 1 plans can form a feasible Pareto
surface. This finding led to the clinically feasible application of
MCO, which was first implemented in the RayStation TPS
(RaySearch, Stockholm, Sweden). The MCO has also become
available in the recent version of the Eclipse TPS. In these
TPSs, users select the optimal plan by adjusting the combina-
tion of dosimetric criteria through interactive sliding bars (ie, a
posteriori interaction).
The MCO can also be implemented in the a priori approach
with a set of defined dosimetric preferences before the inverse
optimization. Only a single optimal plan is generated with full
automation, and thus, it requires no need for human interac-
tions. This approach was proposed by Breedveld et al in their
work of IMRT Cycle (iCycle).52,53 In iCycle, the generation of
the optimal plan is governed by a “wish list,” which contains
the desired dosimetric criteria with assigned priorities in order.
During the optimization, these criteria are sequentially mini-
mized according to the ascribed priorities to reach the desired
plan on the Pareto surface. In addition, iCycle allows beam
arrangement optimization, including beam number and beam
angle. Full Pareto-optimal plans for each number of beam
directions can be used as outputs for human’s a posteriori
interaction. So far, iCycle and its derived platform have been
demonstrated in IMRT planning of head and neck,53 spine,54
prostate,55 pelvis,56 and gastric cancers.57
Novel AI Applications in ATP
Future treatment planning process using a powerful AI agent
can be effective and efficient with minimum human interven-
tion. Figure 1E demonstrates the role of AI in future treatment
planning workflow. We envision that AI can implement all
human operations and reasoning logics based on the compre-
hensive analysis of patient anatomy. Parameter such as treat-
ment prescription and delivery technique can be specified as
human inputs from physicians, but these parameters can be
incorporated into AI decision-making. The future workflow
involves minimum human efforts from human planners and
physicians; the saved human efforts can be used for other
human-centered clinic care tasks.
Currently, a few emerging research topics have been
reported focusing on the ATP. While there is also active
research ongoing along the directions discussed in the above-
mentioned section, this section focuses on the novel AI algo-
rithms in ATP, primarily deep learning–based approaches with
deep architecture and compositionality.58 In this section, we
discuss recent pioneering efforts of novel AI applications in
ATP and introduce a few emerging research directions.
Recent Progresses of AI in ATP
A knowledge-based modeling approach was one of the earliest
breakthroughs in ATP. Boutilier et al evaluated the clinical
applicability of the simultaneous prediction of optimization
objective weights for prostate IMRT. Using optimal weights
of objectives in previous cases, multinomial logistic regression
and weighted K-nearest neighbor algorithms were deployed in
the training of weight prediction.59 Results showed that both
methodologies could produce good predictions for clinical
plans, although no significant performance improvements were
found in comparison with the model using logistic regression.
Ma et al proposed knowledge-based modeling using support
vector regression (SVR).60 In their work, a PTV-only optimi-
zation in the absence of OAR considerations was used as the
model input in addition to anatomical/geometrical features, and
DVH prediction was implemented by SVR as a robust super-
vised learning technique. In a comparison study, this model
was more accurate than the RapidPlan model in bladder and
rectum DVH prediction.60
Another major research area in ATP is the prediction of
spatial dose distribution. While DVH-based prediction is pre-
valent, its lack of spatial information may not reveal certain
dosimetric end points, such as dose conformity and gradient
measurements. Accurate spatial dose distribution prediction
can provide guidance for humans in decision-making during
the manual treatment planning process for potentially
improved quality and efficiency. In addition, the predicted dose
distribution can be used for a fully automated ATP workflow
without the need for DVH-based inverse optimization. Camp-
bell and Miften developed an artificial neural network dose
models for spatial dose distribution prediction of pancreatic
stereotactic body radiation therapy (SBRT).61 The network was
trained by clinical plans with plan parameters voxel-based geo-
metric parameters. Results showed promising accuracy of 3D
dose distribution. Nguyen et al used a modification on the
U-net architecture for coplanar prostate IMRT dose distribution
prediction.62 Based upon fully convolutional networks, U-net
was proposed for image segmentation with transposed convo-
lution operations to maintain original image dimension.63
U-net allows direct image input which avoids the feature
extractions (handcrafted feature selections). This could reduce
the requirement of data interpretation during the classic
modeling process (eg, knowledge-based modeling process).
In 2D-based prediction, the average values of absolute dose
difference were found to be around 2% in PTV and under
5% of the prescription dose in OARs.62 Similarly, Kearney et
al proposed a fully convolutional volumetric dose prediction
neural network (DoseNet) for 3D dose distribution prediction
Wang et al 5
of prostate SBRT with possible noncoplanar treatment regi-
men.64 Compared to U-net, DoseNet was claimed to have
reduced network redundancy as a result of the inclusion of
residual blocks. Chen et al adopted a published convolutional
neural network (CNN) model, ResNet,65 for the dose distribu-
tion prediction of nasopharynx cancer in simultaneous inte-
grated boost radiotherapy.66 This prediction model was used
to predict a coarse dose map of each patient with reduced
intensity content, and a full dose map was recovered from the
coarse dose map by a Gaussian regularized low-pass filter.
Based on a combined architecture of DenseNet and U-net,67
Barragan-Montero et al incorporated beam angle variation in
lung IMRT and developed a model that can predict spatial dose
distribution with varying beam arrangement.68
Successful prediction of dosimetric parameters has to be
converted to clinical treatment plans. A few studies have
explored the feasibility of automatic plan generation that can
lead to deliverable plans. Long et al proposed a framework of
threshold-driven optimization for reference-based auto-
planning, which automatically generates a treatment plan from
a predicted reference DVH set derived from voxel-based dose
distribution.69 Mahmood et al proposed a KBP workflow for
plan generation.70 For oropharyngeal IMRT plan, 3D dose dis-
tribution was predicted, and the actual plan was generated for-
wardly by using DVH-based optimization and a set of
constraints at predetermined dose–volume coordinates. In a
recent study reported by Fan et al,71 3D dose distribution in
head and neck cancer was first predicted by a ResNet-based
framework. For plan generation, instead of DVH-based inverse
optimization, the inverse problem was solved by an L2-norm
problem between the predicted dose distribution and the actual
dose distribution. An open-source software of fluence map
optimization was utilized for this L2-norm problem, and clini-
cally acceptable plans were generated.72
Emerging Research Directions of AI in ATP
The CNN-based algorithms, particularly deep CNN algorithms
with large numbers of hidden layers, have been recently exten-
sively studied in medical imaging, making image-based AI
applications a dominant topic in ATP research. Along this
research direction, dose distribution prediction to further
improve the dose prediction accuracy and efficiency remains
the focus. This may lead to a paradigm shift in plan generation:
Instead of DVH-based optimization, a plan can be generated as
an image reconstruction problem when using predicted dose
distribution as the reference data. Direct prediction of plan
parameters could become another potential research area. If
certain plan parameters can be converted to 2D/3D space
object(s) (“equivalent images”), CNN-based algorithms may
be utilized for the prediction, which can lead to automatic plan
generation. Potentially, 2D fluence maps of static IMRT
beams, 2D aperture series of step-and-shoot delivery, and
dynamic multi-leaf collimator sequences (2D þ time) of
VMAT may be candidates for such predictions.
While most recent AI studies in radiation oncology focused
on predictions, few have simulated the reasoning process in
treatment planning. In the manual treatment planning process,
the decision-making strategy when solving a specific dosi-
metric trade-off problem varies among different planners; one
with more experience may make effective actions more effi-
ciently than another qualified planner with less experience.73
Decision-making strategy will be central to the implementation
of ATP with fully automated workflow without human
intervention.
In manual treatment planning, each decision regarding dose
trade-offs leads to one or more actions in series; this feature is
well suited for reinforcement learning, which led to the success
of AlphaGo, the famous AI success in the board game Go that
had been challenging for conventional computer algorithms.74
Reinforcement learning has 2 distinct features: a trial-and-error
search and a delayed reward.75 With a defined reward function,
the agent attempts to learn the reward function value in each
state and takes actions to maximize the reward. Reinforcement
learning can also be realized by a direct policy search, in which
the agent attempts to learn the reward functions that directly
map observations to actions. Like the board game Go, radio-
therapy treatment planning consists of sequential actions and
long-term consequences. However, unlike board game applica-
tions in which problems are deterministic, fully observable, single
objective with easy reward definition, radiotherapy treatment
planning process is (semi-) stochastic, partially observable, and
multiobjective with a challenging definition of reward. These
characteristics have to be acknowledged for using reinforcement
learning in ATP. For example, an ATP agent can allow only 1 or 2
actions for reinforcement learning (such as DVH constraint
weight adjustment or auxiliary planning structure generation via
Boolean operations), and the reward has to be defined in a simple
way with a numerical scale (eg, target coverage percentage). In
summary, to simulate the human reasoning process, reinforce-
ment learning has to be implemented from a simple problem on
a small scale before its extension to the full ATP workflow.
Another possible approach of implementing decision-
making process in ATP is using generative adversarial
networks (GANs), a class of algorithms that generate represen-
tative samples from a set of training data by implementing 2
competing networks in a zero-sum task.76 These 2 competing
networks, the generator and the discriminator, are trained
simultaneously: While the generator is trained in generating
samples, the discriminator is trained to assess whether the sam-
ples are “good.” The GANs have been investigated in natural
language processing and computer vision. Recently, GANs
have been utilized in medical image segmentation and disease
diagnosis.77,78 The GANs have also been reported for dose
distribution for radiotherapy.70 To simulate decision-making
for treatment planning, GANs can be used in the model-
based reinforcement learning to learn about the environment
so that the reinforcement learning agent can take advantage of
the previously learned environment (model) instead of simply
relying on interaction with the environment (trial-and-error
experience). The 2 trained networks must have a competitive
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relationship in GANs; such a relationship can be simulated by a
plan producer that utilizes the predicted plan distribution and a
dose distribution predictor that requires produced treatment
plans for its training.
Challenges of AI in ATP
Complexity in Treatment Planning: What Should AI
Learn?
Like a self-driving vehicle, the treatment planning process can
involve a large number of consequential actions. However,
unlike those in a self-driving vehicle or a board game, actions
in treatment planning may not have direct consequences (ie,
any operation during the plan generation has to be evaluated
many steps later after the final dose calculation). Thus, simula-
tion of ATP workflow is more computationally expensive com-
pared to board game applications.
To reduce the simulation cost, the complexity of the
decision-making logic has to be settled on a manageable level.
Fortunately, researchers can reduce such complexity by enfor-
cing basic rules during ATP. The current common practice of
manual treatment planning follows rules from different aspects,
including machine hardware limitation (eg, forbidden zones for
noncoplanar beam angle selection due to collision),
radiological-based clinical preferences (eg, prioritized duode-
num sparing in liver/pancreas SBRT), and institutional practice
guidelines (eg, a beam setup template for standardized bilateral
neck IMRT). Integration of these rules by fixing involved vari-
ables or enforcing simple “if-else” logic can reduce the ATP
workflow complexity. In addition, observations following
physical science rules (eg, photon dose requires build-up region
with possible coverage reduction of a target near the skin sur-
face) can be integrated into an ATP workflow to further reduce
the learning complexity. As a result, building a reasonable ATP
workflow for AI training requires a team effort, including
radiation physicists, radiation oncologists, radiation dosime-
trists, radiation therapists, and other personnel involved in
radiotherapy plan generation and verification.
Working With Limited Size Data Sets
Recent progress in deep learning algorithms for imaging appli-
cations has been propelled by large-scale data sets. Compared
to natural image data sets, medical image data sets have smaller
sample sizes for a number of reasons: smaller sample space,
patient recruitment, data acquisition variation, lack of infra-
structure, and labor-intensive image processing by human
experts.4,79 This limitation is compounded for ATP applica-
tions, due to the need for specific types of radiotherapy plans,
a significant constraint, given the continued advancement and
often short histories of modern treatment planning approaches.
So far, most reported ATP studies have included 100 or
fewer patients, which is usually acknowledged as a small size
data set in the discussion of these studies. Furthermore, the
useful data size may get even smaller if confounding variables
such as human variations have to be reduced. Relevant studies
have reported that dose prediction accuracy could be improved
when cases from 2 different radiation oncologists were trained
separately.61 In addition, the limited size of data sets is exacer-
bated by the need for separated training and test data. Ideally,
each data set should be separated into 3 subsets: training data,
validation data, and test data. Training and validation data are
used to train the model, whereas the validation data are used to
tune the model during training. Model training can be carried
out in a cross-validated fashion. The test data should be used to
test the model performance after model validation; these data
should be segregated from the model training. When using the
limited size data for ATP, however, the test data set is some-
times not used and the validation results are reported as the
study end point. However, it is important to note that for increas-
ingly complex AI methods such as those discussed in section 3, a
sufficiently large, well-curated, and controlled database and a
rigorous model training and testing process following the 3-part
data splitting described earlier are especially critical. Without
them, overfitting, a modeling error where the model perfor-
mance is overestimated, tends to happen when an overly com-
plex model is developed based on a limited data set. Using data
sets of practically limited small sizes for dose prediction in
knowledge-based treatment planning, the more complex algo-
rithms were indeed shown to perform inferiorly to the simpler
approaches, likely due to overfitting.80
This overfitting limits model generalization when dealing
with new data. One potential approach to counteract size lim-
itations is transfer learning, which generates a model by using a
small size data set to tune a model which is trained by a larger
data set from another domain.81 A commonly used data set for
pertaining of deep learning models for medical image studies
(particularly CNN) is ImageNet, which is composed of natural
scene images.81,82 Data augmentation is another approach for
dealing with limited data. In general, data augmentation
increases the usable number of data by adding altered versions
of the original data.83 A simple example is to add affine image
transformations (translations, rotations, and scaling) to the
original image sets during the data training for autosegmenta-
tion. A third approach is to incorporate high-level handcrafted
features in model learning, which should be treated as repre-
sentative statistics from small data sets based on previous
endeavors. Additional operations can be added into the network
topology to avoid overfitting.84 However, this approach
requires good knowledge of AI algorithms at a low hierarchy
level, which can be challenging for those without a compre-
hensive computer science background. For ongoing deep learn-
ing–based ATP research, it will be interesting to see how the
above methods can be adapted and new methods developed to
overcome the critical data size limitation.
Toward Clinical Application: Regulation and
Collaboration
Although the future of AI in ATP remains in motion, radio-
therapy treatment planning will likely not become “driver-less”
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in the next coming years. The AI-based ATPs must be validated
before being introduced into routine clinical use.85 Quality and
efficiency improvements should be the focus when evaluating
an AI-based ATP method at the current stage. Humans should
remain as the center of the treatment planning process in over-
seeing the clinical treatment planning workflow with ultimate
responsibility for plan safety and quality.
Successful validation of AI-based ATP methods requires a
large patient cohort size. In addition, for each patient, multiple
data types, including multimodality simulation images, treat-
ment plan, radiogenomic tests, and clinical data, may be nec-
essary for methodology development and validation and
generalizability. Such an endeavor may require new paradigms
of data regulation and supervision in addition to the standard
institutional review board functions. Multicenter collaborations
could augment patient cohort size for methodology develop-
ment and validation. However, retrospective data with signif-
icant variations among different institutions’ practice may
become a problem when investigating AI-based ATP, particu-
larly in the simulation of reasoning logics. Prospective multi-
institution studies with detailed guidelines of treatment plan
generation are fundamental for future studies. Over the past
decade, similar efforts on conforming structure naming to the
nomenclature standardization by professional society commit-
tees, vendors, and the clinical community have made great
strides that substantially facilitated radiotherapy big data
research. Therefore, larger numbers of plans from recent clin-
ical trials with rigorous planning guidelines and from the sub-
sequent protocol adoption are expected to yield better quality
data for AI-based ATP research. Meanwhile, clinical utiliza-
tion of the current ATP tools may also help generate plans of
more consistent quality among planners and institutions, which
could in turn facilitate future AI-based treatment planning
research. Finally, each step in the treatment planning workflow
requires great engineering efforts to ensure accuracy and
safety. For proof-of-concept studies, open software packages
can be adopted when demonstrating the feasibility of new AI
applications in ATP.72,86 However, when considering clinical
validation, a more robust platform based on the vendor-specific
automation function should be used. This may require a new
model of academic/industrial cooperation to deal with potential
issues in data security and intellectual proprietary conflicts and
to ensure the active quality assurance that is critical during the
clinical deployment of the new tool.
Conclusion
In this work, the current ATP solutions have been reviewed
based on their technical characteristics and clinic workflow
impacts. In reported clinical investigations, the discussed solu-
tions have demonstrated the improved planning efficiency and
plan quality consistency. Artificial intelligence in ATP is an
emerging field and is rapidly developing. Recent research
works of AI in ATP, particularly deep learning–based investi-
gations, have been summarized. In addition, future research
directions regarding AI in ATP have been proposed. Finally,
challenges of AI research in ATP and practical issues of poten-
tial preclinical and clinical investigations have been discussed.
We believe that AI technologies would eventually change the
paradigm of radiotherapy treatment planning practice. While
embracing the promising future, current researchers should be
aware of the limitations of current practice and possible
research opportunities of AI to meet health-care needs in the
next or 2 decades.
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